Virtu KCG Holdings’s Novartis NVS Stock Holding History

Virtu KCG Holdings’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,464	Closed	-$371K	–	3662
2014 Q4	$371K	Buy	4,464 +1,228	+38%	+$102K	0.01%	2077
2014 Q3	$273K	Sell	3,236 -3,237	-50%	-$262K	0.01%	2486
2014 Q2	$525K	Buy	+6,473	New	+$509K	0.01%	1899
2014 Q1	–	Sell	-9,709	Closed	-$699K	–	3905
2013 Q4	$699K	Buy	9,709 +223	+2%	+$15.5K	0.01%	1572
2013 Q3	$652K	Buy	+9,486	New	+$628K	0.01%	1667

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's NVS Position: Q2 2017 in Review

Virtu KCG Holdings increased its Novartis (NVS) stake by 421% in Q2 2017, buying an estimated $3.66M and bringing the position to 63,895 shares worth $4.78M. The position accounts for 0.13% of the portfolio, ranked #67.

Virtu KCG Holdings first reported a position in NVS in Q3 2013 and has held it in 16 quarters since. The position peaked at $52.2M in Q1 2014. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Virtu KCG Holdings held 63,895 shares of Novartis worth $4.78M as of Q2 2017.
Virtu KCG Holdings bought 51,638 Novartis shares in Q2 2017, an estimated $3.66M.
Novartis made up 0.13% of Virtu KCG Holdings's portfolio in Q2 2017, its #67 holding.
Virtu KCG Holdings first reported a position in Novartis in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Novartis position peaked at $52.2M in Q1 2014.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.